Mitsubishi Chemical Group Corporation

DB:M3C Stock Report

Market Cap: €7.0b

Mitsubishi Chemical Group Valuation

Is M3C undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Share Price vs Fair Value

What is the Fair Price of M3C when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
€10.88
Fair Value
56.1% undervalued intrinsic discount
11
Number of Analysts


Key Valuation Metric

Which metric is best to use when looking at relative valuation for M3C?

Key metric:

The above table shows the Price to Earnings ratio for M3C. This is calculated by dividing M3C's market cap by their current earnings.
What is M3C's PE Ratio?
PE Ratio12.1x
EarningsJP¥93.31b
Market CapJP¥1.13t

Price to Earnings Ratio vs Peers

How does M3C's PE Ratio compare to its peers?

The above table shows the PE ratio for M3C vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average43.8x
BAS BASF
83.7x32.8%€41.6b
EVK Evonik Industries
36.9x33.0%€8.5b
FPE3 Fuchs
19.3x8.6%€5.0b
SY1 Symrise
35.2x14.1%€13.8b
M3C Mitsubishi Chemical Group
12.1x21.1%€1.1t


Price to Earnings Ratio vs Industry

How does M3C's PE Ratio compare vs other companies in the European Chemicals Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
M3C 12.1xIndustry Avg. 17.6xNo. of Companies13PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies


Price to Earnings Ratio vs Fair Ratio

What is M3C's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

M3C PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio12.1x
Fair PE Ratio26.1x


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Price Target
Consensus Narrative from 11 Analysts
€6.19
Fair Value
22.7% undervalued intrinsic discount
11
Number of Analysts


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/01 20:25
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Mitsubishi Chemical Group Corporation is covered by 22 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mikiya YamadaBarclays
Takashi EnomotoBofA Global Research
Atsushi IkedaCitigroup Inc